Investor Relations

Biography

Krishnan Nandabalan, Ph.D.

Krishnan Nandabalan, Ph.D.

Board Member
Dr. Nandabalan brings over two decades of experience across multiple functions in the pharmaceutical and biotechnology industries, including research & development, operations, and business development. He has extensive experience in M&A and in/out-licensing. He holds 12 issued patents and has published in leading journals such as Cell and Science. Dr. Nandabalan has garnered a deep understanding of market trends impacting the global healthcare environment, the pharma value chain, current unmet medical needs, and in the application of novel technologies to address these needs. For over ten years, he has led the pioneering development of big data analytics and machine learning at BioXcel [Corporation], and its application in drug discovery and development. Dr. Nandabalan holds a B.Sc. and M.Sc. in agricultural science from Tamil Nadu Agricultural University and a Ph.D. in biochemistry and molecular biology from Indian Institute of Science.